10-QPeriod: Q2 FY2012

AXON ENTERPRISE, INC. Quarterly Report for Q2 Ended Jun 30, 2012

Filed August 9, 2012For Securities:AXON

Summary

TASER International, Inc. (now Axon Enterprise, Inc.) reported a significant turnaround in its financial performance for the quarter ended June 30, 2012, compared to the same period in the prior year. The company achieved a net income of $3.4 million, a substantial improvement from a net loss of $2.3 million in Q2 2011. This positive shift was driven by a robust increase in net sales, up 33.1% to $28.2 million, primarily fueled by the strong adoption of its TASER X2 conducted energy device and growth in its Video segment, including AXON on-officer cameras and EVIDENCE.com services. Furthermore, the company demonstrated improved operational efficiency, with a decrease in Sales, General & Administrative (SG&A) expenses as a percentage of net sales and a gross margin increase to 58.5%. The company also reported positive cash flow from operations, offsetting significant spending on its stock repurchase program. While facing ongoing litigation, the company's core business shows signs of strengthening, supported by product innovation and strategic segment focus.

Financial Highlights

46 data points
Beta

Revenue

$28.22M

58.5% Gross Margin

Net Income

$3.44M

12.2% Net Margin

EPS (Diluted)

$0.06

Total Assets

$97.76M

Cash & Equivalents

$17.97M

Free Cash Flow

$9.42M

Financial Statements
Beta
Revenue$28.22M
Cost of Revenue$11.72M
Gross Profit$16.50M
R&D Expenses$2.04M
SG&A Expenses$8.40M
Operating Income$6.06M
Net Income$3.44M
EPS (Basic)$0.06
EPS (Diluted)$0.06
Shares Outstanding (Basic)54.52M
Shares Outstanding (Diluted)55.17M

Key Highlights

  • 1Net income of $3.4 million for Q2 2012, a significant improvement from a net loss of $2.3 million in Q2 2011.
  • 2Net sales increased by 33.1% to $28.2 million in Q2 2012, driven by strong performance in both the ECD and Video segments.
  • 3The TASER X2 device saw significant adoption, contributing $7.1 million in sales for Q2 2012.
  • 4Gross margin improved to 58.5% in Q2 2012 from 57.7% in Q2 2011, indicating better cost management and product mix.
  • 5SG&A expenses decreased by 7.3% to $8.4 million and represented a lower percentage of net sales (29.8% in Q2 2012 vs. 42.8% in Q2 2011).
  • 6The company actively repurchased shares, spending $16.1 million on its stock repurchase program in Q2 2012.
  • 7Positive cash flow from operations of $13.4 million for the first six months of 2012.

Frequently Asked Questions

The primary driver was a significant increase in net sales, up 33.1% to $28.2 million. This growth was largely attributed to the strong adoption of the new TASER X2 conducted energy device and increased sales in the Video segment, including AXON on-officer cameras and EVIDENCE.com services.

The company demonstrated improved expense management. Sales, General & Administrative (SG&A) expenses decreased by 7.3% and represented a much lower proportion of net sales (29.8% in Q2 2012 vs. 42.8% in Q2 2011). This, combined with a higher gross margin of 58.5%, contributed significantly to the company's return to profitability, with net income of $3.4 million compared to a net loss in the prior year.

As of June 30, 2012, the company had approximately $17.97 million in cash and cash equivalents and $5.19 million in short-term investments. The company generated $13.4 million in cash flow from operations during the first six months of 2012. However, it also utilized $15.7 million in financing activities, primarily for its stock repurchase program, which saw $16.1 million spent in the second quarter.

The company continues to face product liability litigation, with 36 lawsuits alleging wrongful death or personal injury in which a TASER device was used. While many cases have been dismissed in favor of the company, a notable case in North Carolina resulted in a jury award that, after remittitur, led to a $5.5 million judgment. The company is appealing this judgment. The company also faces risks related to market acceptance of new products, competition, and potential regulatory changes.